News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
The China NMPA Approves TYVYT® (sintilimab injection) in Combination with Bevacizumab and Chemotherapy in Patients with EGFR-mutated Non-squamous NSCLC who Progressed after EGFR-TKI Therapy
Wednesday, May 10, 2023Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of cancer autoimmune metabolic ophthalmology and other major diseases and Eli Lilly and...
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Wednesday, May 10, 2023Ultomiris ravulizumab has been approved in the European Union EU as the first and only longacting C complement inhibitor for the treatment of adult patients with antiaquaporin AQP antibodypositive Ab neuromyelitis optica spectrum disorder NMOSD
Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals
Tuesday, May 09, 2023Singlera Genomics a company focused on the application of novel DNA methylation technologies to genetic diagnosis today announced that it had received Breakthrough Device Designation from the Food and Drug Administration FDA for its PDACatch assay a...
FDA accepts application for Roches Vabysmo for the treatment of retinal vein occlusion (RVO)
Tuesday, May 09, 2023Roche SIX RO ROG OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA for Vabysmo faricimab for the treatment of macular edema following retinal vein occlus...
Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication
Friday, May 05, 2023Long Grove Pharmaceuticals announced the strategic inlicensing of Norepinephrine in Sodium Chloride premix formulation from Nevakar Injectables Inc This manufactured readytouse formulation is roomtemperature stable and will be available in three com...
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Thursday, May 04, 2023The US Food and Drug Administration approved Arexvy the first respiratory syncytial virus RSV vaccine approved for use in the United States Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals years o...
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
Thursday, May 04, 2023SHL Medical a worldleading provider of advanced drug delivery solutions announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics a clinicalstage biotechnology company focused on creating nextlevel therapies for inflamma...
LenioBio GmbH Announces New CEO
Thursday, May 04, 2023LenioBio GmbH the Dsseldorfbased cellfree protein expression company has announced that its founder and CEO Dr Remberto Martis will be stepping down as CEO and has proudly named his successor as Andr Goerke starting June st Andre has previously held...
Lantern Pharma Develops Top-Ranked AI Algorithms to Predict the Blood-Brain-Barrier Permeability of Any Compound
Wednesday, May 03, 2023Lantern Pharma Inc a clinicalstage biopharmaceutical company using its proprietary RADR artificial intelligence AI and machine learning ML platform to transform the cost pace and timeline of oncology drug discovery and development today announced tha...
Tris Pharma Expands Leadership Team as Company Broadens Commercial Portfolio and Progresses Clinical Pipeline
Wednesday, May 03, 2023Tris Pharma Inc Tris a commercialstage biopharmaceutical company focused on ADHD pain and neurological disorders today announced the appointments of Thomas Englese as chief commercial officer and Marc Lesnick PhD as chief development officer We are t...
